Histone Deacetylase Inhibitors Research

13 works

1. Remodeling “cold” tumor immune microenvironment via epigenetic-based therapy using targeted liposomes with in situ formed albumin corona

   Yang He, Yuefei Fang, Meng Zhang +7

   ArticleHistone Deacetylase Inhibitors ResearchActa Pharmaceutica Sinica B20214 citations

   ABIABI:AkademIndex/openalex/2021.article.000056

2. Targeted Protein Degradation in Cancer: PROTACs, New Targets, and Clinical Mechanisms

   Bushra Faryal, Zain Ul Abideen, Muhammad Irfan +4

   ArticleProtein Degradation and InhibitorsBiomolecules20262 citations

   ABIABI:AkademIndex/openalex/2026.article.000038

3. Demethyldihydroglycyrin tetraacetate

   Shakhnoza S. Azimova, Валентина И. Виноградова

   ChapterHyperglycemia and glycemic control in critically ill and hospitalized patients20120 citations

   ABIABI:AkademIndex/openalex/2012.chapter.003285

4. 28-epi-Isocyasterone

   Shakhnoza S. Azimova

   ChapterOrganic Chemistry Cycloaddition Reactions20120 citations

   ABIABI:AkademIndex/openalex/2012.chapter.006289

5. Nanotherapeutic macrophage-based immunotherapy for the peritoneal carcinomatosis of lung cancer

   Yonghui Wang, Binfan Chen, Zhidi He +7

   ArticleHistone Deacetylase Inhibitors ResearchNanoscale20210 citations

   ABIABI:AkademIndex/openalex/2021.article.000556

6. The Effect of Ecdystene on the Activity of Matrix Metalloproteinases in Experimental Alloxan Diabetes in Rats

   D. Tursunov, Rixsi A. Sabirova, М. У. Кульманова +5

   ArticleProtease and Inhibitor MechanismsBioNanoScience20210 citations

   ABIABI:AkademIndex/openalex/2021.article.003259

7. A perspective on emerging therapies in metastatic colorectal cancer: Focusing on molecular medicine and drug resistance

   Anggraeni Endah Kusumaningrum, Sarce Makaba, Eyhab Ali +6

   ArticleColorectal Cancer Treatments and StudiesCell Biochemistry and Function20240 citations

   ABIABI:AkademIndex/openalex/2024.article.000842

8. Ubiquitylation in the development of somatic diseases: a mechanism of cellular regulation and a new therapeutic target

   Александр Ураков, Anton Tyurin, V. S. Shchekin +4

   ArticleUbiquitin and proteasome pathwaysReviews on Clinical Pharmacology and Drug Therapy20240 citations

   ABIABI:AkademIndex/openalex/2024.article.010125

9. AML-489: Combination of Azacitidine and Venetoclax in Patients With Acute Myeloid Leukemia: A Single-Center Experience

   Farhodjon Tashtemirov, Z.V. Yunusova, M Islamov +3

   ArticleAcute Myeloid Leukemia ResearchClinical Lymphoma Myeloma & Leukemia20250 citations

   ABIABI:AkademIndex/openalex/2025.article.008096

10. Therapeutic innovations: targeting ROS production in AML with natural and synthetic compounds

    Mohammed H. Mohammed, Raed Fanoukh Aboqader Al-Aouadi, Subasini Uthirapathy +7

    Review articleHistone Deacetylase Inhibitors ResearchNaunyn-Schmiedeberg s Archives of Pharmacology20250 citations

    ABIABI:AkademIndex/openalex/2025.review-article.000155

11. Epigenetic regulation of EZH2 by ncRNAs: mechanisms and oncogenic implications

    Hussein Salim Abed, N. Esanmurodova, Abhinav Kumar +6

    Review articleEpigenetics and DNA MethylationNaunyn-Schmiedeberg s Archives of Pharmacology20250 citations

    ABIABI:AkademIndex/openalex/2025.review-article.000168

12. Epigenetic clocks and biological aging acceleration in early-onset hypertension

    Alisher Axrorov, Elvina Midatovna Sharipova, Nodirbek Xamidov +3

    ArticleEpigenetics and DNA MethylationZenodo (CERN European Organization for Nuclear Research)20260 citations

    ABIABI:AkademIndex/openalex/2026.article.007340

13. Epigenetic clocks and biological aging acceleration in early-onset hypertension

    Alisher Axrorov, Elvina Midatovna Sharipova, Nodirbek Xamidov +3

    ArticleEpigenetics and DNA MethylationZenodo (CERN European Organization for Nuclear Research)20260 citations

    ABIABI:AkademIndex/openalex/2026.article.007396